Cite

    Mckie, J. et al. (2014). Trends in Bone Morphogenetic Protein Usage since the U.S. Food and Drug Administration Advisory in 2008: What Happens to Physician Practices When the Food and Drug Administration Issues an Advisory?. Global spine journal. pp. 071-076. [Online].